News Releases & Media Coverage
AI and the Digital Disruption of Life Sciences: Dr. Cherkasov Presents at Princess Margaret
Dr. Artem Cherkasov, Co-Founder and President of Artemis Therapeutics, delivered an invited lecture titled “Digital Disruption of Life Sciences with Artificial Intelligence” as part of the Princess Margaret Distinguished Speaker Seminar Series at the University Health...
From Prompt to Patient: Dr. Cherkasov Joins EuroQSAR 2026 Roundtable
Dr. Artem Cherkasov, Co-Founder and President of Artemis Therapeutics, participated as an invited panel member at the 25th EuroQSAR Symposium, held in Perugia, Italy, from September 27 to October 1, 2026. Dr. Cherkasov joined the roundtable discussion titled “From...
Navigating the Chemical Universe: Artemis Co-Founder Presents at Cedars-Sinai
Dr. Artem Cherkasov, Co-Founder and President of Artemis Therapeutics, delivered an invited lecture titled “AI Navigation of Chemical Universe for Therapeutic Candidates” at the Cedars-Sinai Translational Research Institute in Los Angeles, California, on September 3,...
Dr. Cherkasov Shares Lessons from CACHE Challenges at ACS Fall 2026
Dr. Artem Cherkasov, Co-Founder and President of Artemis Therapeutics, delivered an invited lecture titled “Democratization of Drug Discovery: Lessons Learnt from CACHE Challenges” at the American Chemical Society (ACS) Fall Meeting, held in Chicago, Illinois, from...
Exploring Clinical Applications of DeepDocking™: Dr. Cherkasov Presents at CCOCR 2026
Dr. Artem Cherkasov, Co-Founder and President of Artemis Therapeutics, delivered an invited lecture titled “DeepDocking in Drug Discovery – Clinical Examples” at the Canadian Conference on Ovarian Cancer Research (CCOCR), held in Vancouver, British Columbia, from May...
Dr. Artem Cherkasov Delivers Keynote on the Future of AI in Drug Discovery at UBC
Dr. Artem Cherkasov, Co-Founder and President of Artemis Therapeutics, delivered a keynote lecture titled “The Future of AI in Drug Discovery” at the Graduate and Postdoctoral Research Symposium (GPRS), hosted by the University of British Columbia's Faculty of...
Artemis Therapeutics Inc. Announces Company Launch and License of Advanced Artificial Intelligence Technology from the University of British Columbia
FOR IMMEDIATE RELEASE Company will utilize its Artemis.AI™ Platform for drug discovery and development and other high-value applications Vancouver, BC — March 13, 2026 — Artemis Therapeutics Inc. is a privately held drug discovery and development...
Let's Advance Discovery Together
If you are interested in partnering, investing, or exploring scientific collaboration, we welcome the conversation.
